Pricing

Log inSign up

InflaRx

35 people · 0 jobs
‌

InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a.

Industries

Biotechnology

Headquarters

Jena, Germany

Employees

11-50

Links

Org chart

Niels C. Riedemann
CEO & Founder
Collapse
Renfeng Guo
Chief Scientific Officer & Founder
Thomas Taapken
Chief Financial Officer
Nicole Bertsch
Senior Director, Head of Human Resources
Jacky Schmitt
Senior Director Manufacturing, ext.
Daniel Vetter
Senior Director, Head of IT
Timothy E. Hermes
VP, Commercial
AP
Anja Pfaff
Director, Head Of Programme Management
Camilla Chong
Chief Medical Officer

Board & advisors

NF
Nicolas Fulpius
Chairman
MK
Mark Kubler
Board Member
Richard Brudnick
Board Member
TG
Tony Gibney
Board Member
Hege Hellstrom
Non Executive Board Member

Offices

Similar companies

BioNTech

35 followers

Tango Therapeutics

3 followers

Cellares

5 followers

Sanofi

320 followers

Gilead Sciences

171 followers

Regeneron

143 followers

Illumina

81 followers

Agilent Technologies

89 followers

Lonza

76 followers

Verily Life Sciences

48 followers

Alexion Pharmaceuticals

49 followers

Explore companies